S.3250 - DHS Opioid Detection Resilience Act of 2020116th Congress (2019-2020)
|Sponsor:||Sen. Cornyn, John [R-TX] (Introduced 02/04/2020)|
|Committees:||Senate - Homeland Security and Governmental Affairs|
|Latest Action:||Senate - 02/04/2020 Read twice and referred to the Committee on Homeland Security and Governmental Affairs. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Summary: S.3250 — 116th Congress (2019-2020)All Information (Except Text)
Introduced in Senate (02/04/2020)
DHS Opioid Detection Resilience Act of 2020
This bill establishes new requirements related to the detection of illicit narcotics at ports of entry.
Specifically, U.S. Customs and Border Protection (CBP) must implement a strategy to ensure chemical screening devices are able to identify narcotics at purity levels equal to or less than 10%, or provide an alternate method for identifying narcotics at lower purity levels. The CBP must also test new chemical screening devices at various purity levels before it commits to their acquisition.
Additionally, the Department of Homeland Security must implement a plan for the long-term development of a centralized spectral database for chemical screening devices.